Nitric Oxide (NO), derived from L-arginine, is produced by two types (constitutive and inducible) of nitric oxide synthase (NOS: cNOS and iNOS). The NO produced in large amounts by the iNOS is known to be responsible for the vasodilation and hypotension observed in septic shock, cancer metastasis an...
Nitric Oxide (NO), derived from L-arginine, is produced by two types (constitutive and inducible) of nitric oxide synthase (NOS: cNOS and iNOS). The NO produced in large amounts by the iNOS is known to be responsible for the vasodilation and hypotension observed in septic shock, cancer metastasis and inflammation. The inhibitors of iNOS, thus, may be useful candidates for the treatment of inflammatory diseases accompanied by the overproduction of NO. We prepared alcoholic extracts of herbal drugs which have been used for the treatment of inflammation in oriental medicine. We have screened the inhibitory activity of NO production in lipopolysaccharide (LPS)-activated macrophages after the treatment of these extracts. Among 82 kinds of extracts of herbal drugs, 35 extracts showed the potent inhibitory activity of NO production above 50% at the concentration of $50\;{\mu}g/mL$. The inhibitory activities of NO production were also evaluated for several solvent fractions at two different concentrations. Especially, hexane and EtOAc fractions of Alpinia officinarum, Angelica gigas, Ostericum koreanum, Saussurea lappa, Torilis japonica, and hexane fractions of Agrimonia pilosa, Machilus thunbergii, Hydrangea serrata, Magnolia obovata, Prunella vulgaris, Tussilago farfara, and EtOAC fractions of Perilla frutescence showed a significant activity at 10 and/or $25\;{\mu}g/mL$. In Western blot analysis, the hexane fractions ($5\;{\mu}g/mL$) of Magnolia obovata and Saussurea lappa, and EtOAc fractions ($20\;{\mu}g/mL$) of Hydrangea Serrata, Perilla frutescence and Torilis japonica inhibited the expression of iNOS protein in LPS-activated macrophages. These plants may be promising candidates for the study of the activity-guided purification of active compounds and might be useful for the treatment of inflammatory diseases and endotoxemia accompanying overproduction of NO.
Nitric Oxide (NO), derived from L-arginine, is produced by two types (constitutive and inducible) of nitric oxide synthase (NOS: cNOS and iNOS). The NO produced in large amounts by the iNOS is known to be responsible for the vasodilation and hypotension observed in septic shock, cancer metastasis and inflammation. The inhibitors of iNOS, thus, may be useful candidates for the treatment of inflammatory diseases accompanied by the overproduction of NO. We prepared alcoholic extracts of herbal drugs which have been used for the treatment of inflammation in oriental medicine. We have screened the inhibitory activity of NO production in lipopolysaccharide (LPS)-activated macrophages after the treatment of these extracts. Among 82 kinds of extracts of herbal drugs, 35 extracts showed the potent inhibitory activity of NO production above 50% at the concentration of $50\;{\mu}g/mL$. The inhibitory activities of NO production were also evaluated for several solvent fractions at two different concentrations. Especially, hexane and EtOAc fractions of Alpinia officinarum, Angelica gigas, Ostericum koreanum, Saussurea lappa, Torilis japonica, and hexane fractions of Agrimonia pilosa, Machilus thunbergii, Hydrangea serrata, Magnolia obovata, Prunella vulgaris, Tussilago farfara, and EtOAC fractions of Perilla frutescence showed a significant activity at 10 and/or $25\;{\mu}g/mL$. In Western blot analysis, the hexane fractions ($5\;{\mu}g/mL$) of Magnolia obovata and Saussurea lappa, and EtOAc fractions ($20\;{\mu}g/mL$) of Hydrangea Serrata, Perilla frutescence and Torilis japonica inhibited the expression of iNOS protein in LPS-activated macrophages. These plants may be promising candidates for the study of the activity-guided purification of active compounds and might be useful for the treatment of inflammatory diseases and endotoxemia accompanying overproduction of NO.
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
이론/모형
The BuOH fraction of Magnolia obovata and Ostericum koreanum also showed the strong inhibition of NO production in LPS-activated macrophages (Table 2). The viabilities of RAW 264.7 cells treated with these samples were assessed to be above 85% by MTT method (Mosmann, 1983) at the sample concentrations used for the nitrite assay. The hexane soluble fraction of Machilus thunbergii and Ostericum koreanum was toxic against RAW 264.
성능/효과
From sixteen herbs including species that showed strong inhibition of NO production, methanol extracts were prepared in a large scale, and solvent fractions of them were prepared with increasing the polarity of solvents. The inhibitory activities of NO production were concentrated to certain solvent fractions; to hexane and EtOAc fractions for Alpinia officinarum, Angelica gigas, Curcuma zedoaria, Forsythia koreana, Hydrangea serrata, Saussurea lappa and Torilisjaponica, to hexane fractions for Agrimonia pilosa, Machilus thunbergii, Magnolia obovata, Poncirus trifbliata, Prunella vulgaris, Schizandra chinensis and Tussilago farfara, to EtOAC fractions for Prunella vulgaris. The BuOH fraction of Magnolia obovata and Ostericum koreanum also showed the strong inhibition of NO production in LPS-activated macrophages (Table 2).
후속연구
The plants showing inhibitory activity of NO production can be promising candidates for the activity- guided isolation of active components having iNOS inhibitory activity, which may have potential for the treatment of endotoxemia and inflammation accompanying overproduction of NO. Further investigation is underway to characterize active constituents present in the extract of plants.
참고문헌 (29)
Achike, F. I., and Kwan, C. Y., Nitric oxide, human diseases and the herbal products that affect the nitric oxide signaling pathway. Clin. Exp. Pharmacol. Physiol. 30, 605-615 (2003)
Billiar, T.R, Curran, RD., Stuehr, D.l., Stadler, J., Simmons, R L., and Murray, S.A., Inducible cytosolic enzyme activity for the production of nitrogen oxide from L-arginine in hepatocytes. Biochem. Biophys. Res. Commun. 168, 1034-1040 (1990)
Bredt, D.S., and Snyder, S.H., Isolation of nitric oxide synthase, a calmodulin-requiring enzyme. Proc. Natl. Acad. Sci. U.S.A. 87,682-685 (1990)
Brouet, I., and Oshima, H., Curcumin, an anti-tumor promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages. Biochem. Biophys. Res. Commun. 206, 533-540 (1995)
Chi, Y.S., Cheon, B.S., and Kim, H.P., Effect of wogonin, a plant flavone from Scutellaria radix, on the suppression of cyclooxygenase-2 and the induction of inducible nitric oxide synthase in lipopolysaccharide-treated RAW 264.7 cells. Biochem. Pharmacol. 61, 1195-1203 (2001)
Choi, S.S., Lee, J.K., Han, E.J., Han, K.J., Lee, H.K., Lee, J, and Suh, H.W., Effect of ginsenoside Rd on nitric oxide system induced by lipopolysaccharide plus TNF-alpha in C6 rat glioma cells. Arch. Pharm. Res. 26, 375-382 (2003)
Choi, Y.E., Ahn, H., and Ryu, J.H., Polyacetylenes from Angelica gigas and their inhibitory activity on the nitric oxide synthesis in activated macrophages. Biol. Pharm. Bull. 23, 884-886 (2000)
Forstermann, D., Schmidt, H. H. H. W, Pollock, J.S., Sheng, H., Mitchell, J.A., Warner, T.D., Nakaue, M., and Murad, E, Isoforms of nitric oxide synthase. Characterization and purification from different cell types. Biochem. Pharmacol. 42, 1849-1857 (1991)
Hong, C.H., Noh, M.S., Lee, W.Y., and Lee, S.K., Inhibitory effects of natural sesquiterpenoids isolated from the rhizomes of Curcuma zedoaria on prostaglandin E2 and nitric oxide production. Planta Med. 68, 545-547 (2002)
Iida, S., Oshima, H., Oguchi, S., Hata, T., Suzuki, H., Kawazaki, H., and Esumi, H., Identification of inducible calmodulindependent nitric oxide synthase in the liver of rats. J. Biol. Chem. 267, 25385-25388 (1992)
Jang, M. K., Lee, H. J., Kim, J. S., and Ryu, J.H., A curcuminoid and two sesquiterpenoids from Curcuma zedoaria as inhibitors of nitric oxide synthesis in activated macrophages, Arch. Pharm. Res. 27, 1220-1225 (2004)
Kilbourn, R.G., and Belloni, P., Endothelial cell production of nitrogen oxides in response to interferon- $\gamma$ in combination with tumor necrosis factor, interleukin-1, or endotoxin. J. Natl. Cancer Inst. 82, 772-776 (1990)
Kilbourn, R.G., Gross, S.S., Jubran, A., Adams, J., Griffith, O. W, Levi, R, and Lodato, R.E, $N^G$ -methyl-L-arginine inhibits tumor necrosis factor-induced hypotention: implication for the involvement of nitric oxide. Proc. Natl. Acad. Sci. U.S.A. 87, 3629-3632 (1990)
Kim, E. J, Jin, H. K., Kim, Y. K., Lee, H. Y., Lee, S. Y., Lee, K. R, Zee, O. P., Han, J. W, and Lee, H. W, Suppression by a sesquiterpene lactone from Carpesium divaricatum of inducible nitric oxide synthase by inhibiting nuclear factor-kappaB activation. Biochem. Pharmacol. 61, 903-910 (2001)
Kim, H. K., Cheon, B. S., Kim, Y. H., Kim, S. Y., and Kim, H. P., Effects of naturally occurring flavonoids on nitric oxide production in the macrophage cell line RAW 264.7 and their structure-activity relationships. Biochem. Pharmacol. 58, 759765 (1999)
Kobuchi, H., Droy-Lefaix, M.T., Christen, Y, and Packer, L., Ginkgo biloba extract (EGb 761): inhibitory effect on nitric oxide production in the macrophage cell line RAW 264.7. Biochem. Pharmacol. 53, 897-903 (1997)
Lee, H. J., Kim, N. Y, Jang, M. K., Son, H.C., Kim, K.M., Sohn, D.H., Lee, S.H., and Ryu, 1.H., A Sesquiterpene, dehydrocostus lactone, inhibits the expression of inducible nitric oxide synthase and - $TNF-{\alpha}$ in LPS-activated macrophages. Planta Med. 65, 104-108 (1999)
Mosmann, T., Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Meth. 65, 55-63 (1983)
Oh, G.S., Pae, H.O., Choi, B.M., Seo, E.A., Kim, D.H., Shin, M.K., Kim, J.D., Kim, J.B., and Chung, H.T., 20(S)Protopanaxatriol, one of ginsenoside metabolites, inhibits inducible nitric oxide synthase and cyclooxygenase-2 expressions through inactivation of nuclear factor-kappaB in RAW 264.7 macrophages stimulated with lipopolysaccharide. Cancer Lett. 205, 23-29 (2004)
Oshima, H., and Bartsch, H., Chronic infectious and inflammation process as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat. Res. 305, 253-264 (1994)
Park, H.J, Jung, W.T., Basnet, P., Kadota, S., and Namba, T., Syringin $4-O-\beta$ -glucoside, a new phenylpropanoid glycoside, and costunolide, a nitric oxide synthase inhibitor, from the stem bark of Magnolia sieboldii. J. Nat. Prod. 59, 1128-1130 (1996)
Ryu, J.H., Son, H.J., Lee, S.H., and Sohn, D.H., Two neolignans from Perilla frutescens and their inhibition of nitric oxide synthase and tumor necrosis factor- $\alpha$ expression in murine macrophage cell line RAW 264.7. Bioorg. Med. Chem. Lett. 12, 649-651 (2002)
Ryu, J.H, Ahn, H., Kim, J.Y., and Kim, Y.K., Inhibitory activity of plant extracts on nitric oxide synthesis in LPS-activated macrophages. Phytother. Res. 17, 485-489 (2003)
Stuehr, D.J., Cho, H.J., Kwon, N.S., Weise, M., and Nathan, C.F., Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: an FAD- and FMN-containing flavoprotein. Proc. Natl. Acad. Sci. U.S.A. 88, 7773-7777 (1991)
Tapondjou, L.A., Lontsi, D., Sondengam, B.L., Shaheen, P., Choudhary, M.l., Atta-ur-Rahman, van Heerden, P.R., Park, H. J., and Lee, K.T., Saponins from Cussonia bancoensis and their inhibitory effects on nitric oxide production. J. Nat. Prod. 66, 1266-1269 (2003)
Thiemermann, C, and Vane, J., Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo. Eur. J. Pharmacol. 182, 591-595 (1990)
※ AI-Helper는 부적절한 답변을 할 수 있습니다.